loteprednol etabonate 5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension
RxNorm concept 545255, clinical drug (scd). Prescribable name: loteprednol etabonate 0.5 % / tobramycin 0.3 % Ophthalmic Suspension.
- RxCUI
- 545255
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/545255 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
loteprednol etabonate 0.5 % / tobramycin 0.3 % Ophthalmic Suspension
Related concepts
- tobramycin 3 MG/ML (SCDC, consists of)
- loteprednol etabonate 5 MG/ML (SCDC, consists of)
- Ophthalmic Suspension (DF, has dose form)
- loteprednol etabonate 5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension [Zylet] (SBD, has tradename)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 545255 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/545255 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 545255. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.